Viking Therapeutics has a consensus rating of Strong Buy which is based on 11 buy ratings, 0 hold ratings and 0 sell ratings. The average price target for Viking Therapeutics is $113.67. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
1 день назад · Viking Therapeutics has a lot of momentum going into 2025. · Its lead candidate appears to be performing well in aiding weight loss. · It also has ... |
2 дня назад · Viking Therapeutics' shares have soared 200% since January. · Its leading candidate for treating obesity helps justify its valuation. · The ... |
55,01 $ Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of A. Style Scorecard. |
Оценка 3,9  · StockInvest.us The Viking Therapeutics stock holds several negative signals and despite the positive trend, we believe Viking Therapeutics will perform weakly in the next ... |
14 окт. 2024 г. · The average brokerage recommendation (ABR) for Viking Therapeutics (VKTX) is equivalent to a Buy. The overly optimistic recommendations of ... |
Оценка 4,7  (7) The consensus among 7 Wall Street analysts covering (NASDAQ: VKTX) stock is to Strong Buy VKTX stock. Out of 7 analysts, 5 (71.43%) are recommending VKTX as a ... |
5 дней назад · Viking Therapeutics (VKTX) is a speculative buy with significant risks, but it also offers potential for investors willing to take on the ... |
Viking Therapeutics, Inc. (VKTX) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated ... |
12 сент. 2024 г. · The average brokerage recommendation (ABR) for Viking Therapeutics (VKTX) is equivalent to a Buy. The overly optimistic recommendations of ... |
| Novbeti > |
| Axtarisha Qayit Anarim.Az Anarim.Az Sayt Rehberliyi ile Elaqe Saytdan Istifade Qaydalari Anarim.Az 2004-2023 |